Previous Article | Next Article 
Molecular and Cellular Biology, December 1998, p. 7397-7409, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Coactivator OBF-1 Makes Selective Contacts with
Both the POU-Specific Domain and the POU Homeodomain and Acts as a
Molecular Clamp on DNA
Patrick
Sauter and
Patrick
Matthias*
Friedrich Miescher-Institute, CH-4058 Basel,
Switzerland
Received 4 August 1998/Accepted 10 September 1998
 |
ABSTRACT |
The lymphoid-specific transcriptional coactivator OBF-1 (also known
as OCA-B or Bob-1) is recruited to octamer site-containing promoters by
interacting with Oct-1 or Oct-2 and thereby enhances the
transactivation potential of these two Oct factors. For this interaction the POU domain is sufficient. By contrast, OBF-1 does not
interact with the POU domains of other POU proteins, such as Oct-4,
Oct-6, or Pit-1, even though these factors bind efficiently to the
octamer motif. Here we examined the structural requirements for
selective interaction between the POU domain and OBF-1. Previous data have shown that formation of a ternary complex among OBF-1, the
POU domain, and the DNA is critically dependent on residues within the
octamer site. By methylation interference analysis we identified bases
that react differently in the presence of OBF-1 compared to the POU
domain alone, and using phosphothioate backbone-modified probes in
electrophoretic mobility shift assays, we identified several positions
influencing ternary complex formation. We then used Oct-1/Pit-1 POU
domain chimeras to analyze the selectivity of the interaction between
OBF-1 and the POU domain. This analysis indicated that both the POU
specific domain (POUS) and the POU homeodomain
(POUH) contribute to complex formation. Amino acids that
are different in the Pit-1 and Oct-1 POU domains and are considered to
be solvent accessible based on the Oct-1 POU domain/DNA cocrystal
structure were replaced with alanine residues and analyzed for their
influence on complex formation. Thereby, we identified residues L6 and
E7 in the POUS and residues K155 and I159 in the POUH to be critical in vitro and in vivo for selective
interaction with OBF-1. Furthermore, in an in vivo assay we could show
that OBF-1 is able to functionally recruit two artificially separated halves of the POU domain to the promoter DNA, thereby leading to
transactivation. These data allow us to propose a model of the
interaction between OBF-1 and the POU domain, whereby OBF-1 acts as a
molecular clamp holding together the two moieties of the POU domain and
the DNA.
 |
INTRODUCTION |
The transcriptional coactivator
called OBF-1 (34), OCA-B (19, 20), or Bob-1
(9) is a proline-rich protein that interacts specifically
with both octamer-binding factors present in B cells, Oct-1 and
Oct-2. It is generally assumed that this interaction is crucial for
octamer motif-mediated gene activation in lymphoid cells. OBF-1
expression is highly cell specific and is found in B lymphocytes of all
developmental stages (31, 34) as well as transiently in T
lymphocytes upon activation (29, 42). Several studies have
shown that OBF-1 can activate transcription in vivo or in vitro by
being recruited by Oct-1 or Oct-2 to the conserved octamer site
of immunoglobulin (Ig) and other promoters (20, 34). While
the Ig promoter is well activated by OBF-1 in such assays, the histone
H2B promoter is only weakly activated, suggesting that OBF-1
trans-activates in a promoter-specific manner (20, 34). In addition, OBF-1 activates only
promoter and not enhancer octamer sites, independently of their
orientation (27, 31).
Targeting of the OBF-1 gene in the mouse has shown that,
surprisingly, B-cell development and initial Ig gene transcription are
unaffected in the absence of this cofactor (14, 24, 30). Yet, in vivo immune responses and germinal center formation are dramatically impaired in these mice, suggesting that critical target
genes for these functions must lie downstream of OBF-1. The defect
appears to be primarily an intrinsic B-cell defect because T-cell
function in these mice is largely normal (30).
Previous studies have shown that OBF-1 forms a ternary complex with
the DNA and full-length protein or the POU domain of Oct-1 or
Oct-2 (POU1 or POU2) but not with Oct-4, Oct-6, or Pit-1
(9, 20, 34). In addition, OBF-1 appears to
influence neither the on rate nor the off rate of the POU
domain-DNA interaction and was shown in vitro to interact with the POU
domain also in the absence of DNA (27, 31). Interestingly,
not every site that binds Oct-1 or Oct-2 allows formation of a
complex with OBF-1, and it was found that in particular the base at
the fifth position of the octamer motif (ATGCAAAT) is
crucial and has to be an A (4, 8). Furthermore, it has been
shown that the N terminus of OBF-1 (amino acids 1 to 118) interacts
weakly with the octamer site in the absence of the POU domain
(4). In vivo coactivation by OBF-1 through different
sites correlates well with the complex formation observed in vitro
(4, 8). Yet other residues are clearly also important,
because there are sites, such as the interleukin 2 distal octamer
site or the gonadotropin-releasing hormone enhancer site
(5), that have a conserved position +5 but fail to
allow ternary complex formation in vitro or to be activated in vivo (reference 8 and our unpublished data).
The POU domain is a bipartite DNA binding protein module
(12) that binds selectively to the DNA octamer motif
ATGCAAAT and a subset of derivatives. The POU1-DNA cocrystal
structure (16) shows two globular domains, the N-terminal
POU specific domain (POUS) and the C-terminal POU
homeodomain (POUH), that are physically connected by the POU linker. The latter is most divergent in sequence and length among the POU domains and is not visible in the
cocrystal, indicating an unstructured conformation. By contrast,
crystal structures of POU1 and the Pit-1 POU domain in addition to
nuclear magnetic resonance data for POU2 show that the POUS
and the POUH are highly conserved in this protein family at
the primary, secondary, and tertiary structure levels. The
POUS and POUH both have a helix-turn-helix (HTH) motif with the third helix binding to the DNA in the major groove. The HTH in the POUS is similar to the one found in
prokaryotic proteins like, for example,
-repressor, cro, or 434 (1, 6, 26). The HTH in the POUH is homologous to
the one found in the eukaryotic homeodomain protein family
members like, for example, engrailed or antennapedia (15,
25). Therefore, the POU domain can be regarded as a conglomerate
of a classical eukaryotic homeodomain and a prokaryotic DNA
binding domain (reviewed in references 11 and
38). The POUS binds to the consensus
subsite, ATGC, of ATGCAAAT, while the POUH binds
to the homeo consensus-derived subsite, AAAT. In the POU1-DNA (H2B
promoter octamer) cocrystal the POU domain binds as a monomer,
with POUS and POUH contacting opposite sides of
the DNA double helix, whereas in the Pit-1 POU-DNA (binding site
derived from the prolactin gene) cocrystal the POU domain binds
as a dimer, with POUS and POUH touching the
same face of the DNA (13). This indicates an extreme
flexibility influenced by the sequence of the DNA binding site.
A number of transcriptional coactivators have been shown to interact
with the POU domain(s) of Oct-1 and/or Oct-2. The herpes simplex virus protein VP16 selectively interacts with the
POU1H domain through position E22; in POU2H
this position is a divergent alanine which precludes complex
formation (18, 28). In addition, VP16 needs the
octamer-flanking DNA sequence TAATGArAT
(homeodomain binding site underlined) for efficient
interaction with POU1 as well as a host cell factor (17,
40).
The RNA polymerase (Pol) II- and Pol III-specific multiprotein
transcriptional coactivator SNAPc/PTF interacts, through the largest of
its four subunits, SNAP190 (41), with the POUS
position E7 of both the POU1 and POU2 domains (21, 23).
SNAPc/PTF itself binds to a conserved proximal sequence element found
in close proximity to an octamer site found in many small nuclear RNA
(snRNA) promoters. This binding is independent of the interaction with the POU domain, but it is enhanced approximately 8- to 10-fold through
cooperative binding with the POU domain (21).
At least two positions of the POU domain are important for complex
formation with OBF-1: L53 and N59 (8). However, these positions are conserved throughout POU domains and therefore cannot account for the selectivity with which OBF-1 interacts only with certain POU domains.
Here we analyzed the selective determinants in the POU domain and in
the DNA required for complex formation with OBF-1. We identified
base and backbone positions of the DNA which influence the efficiency
of ternary complex formation when modified, indicating that OBF-1
is in close proximity to these positions. We found, in agreement with
these findings, that OBF-1 can be UV cross-linked to the DNA site,
together with the POU domain and also by itself weakly. We identified
residues within the POU domain crucial for selective interaction with
OBF-1 in both the POUS and the POUH. Mutation of these critical residues disrupted interaction in vitro and
also in an in vivo recruitment assay. Furthermore, with an in vivo
assay we showed that OBF-1 is able to functionally recruit two
artificially separated moieties of the POU domain to the promoter DNA,
thereby leading to transactivation. Our data therefore support a model
whereby OBF-1 clamps the POU domain together with the DNA by
interacting with both subunits of the POU domain while bridging
the DNA within the octamer motif at several positions.
 |
MATERIALS AND METHODS |
All recombinant DNA work was done according to standard
procedures, and details of the plasmid constructs and methods used are
available on request. Forward primers are written in uppercase, and
reverse primers are written in lowercase. Single letters in the other
style indicate mutations.
Site-directed mutagenesis, in vitro translation, and
electrophoretic mobility shift assays (EMSAs).
Plasmids for the
Oct-1/Pit-1 POU domain chimeras were kindly supplied by W. Herr
(Cold Spring Harbor Laboratory). Coding sequences thereof, with or
without mutations, were amplified by PCR followed by sequential in
vitro T7 transcription and reticulocyte lysate translation (Promega).
The following sequences were used:
CTATTTAGGTGACACTATAGAAACAGACACCATGGAGGAGCCCAGTGA (amplification of OXxX
chimeras), CTATTTAGGTGACACTATAGAAACAGACACCATGGACTCCCCGGAA (amplification
of PXxX chimeras), caggatcctatgggttgattctttttctt (amplification of XXxO chimeras),
caggatcctacgttttcacccgtttttc (amplification of XXxP
chimeras), caggatcctacgttttcacccgtttttctTtc (XXxP with
R155K), caggatcctacgttttGaTccgtttttctctc (XXxP with V159I),
caggatcctacgtAttgacccgtttttctctc (XXxP with K160N),
caggatcctacgGtttcacccgtttttctctc (XXxP with T161P),
caggatcctacgttttGaGccgtttttctTtc (XXxP with V159I-R155K),
caggatcctacgGAttcacccgtttttctctc (XXxP with
T161P-K160N), and caggatcctacgGAttGaTccgtttttctTtc
(XXxP with T161P-K160N-V159I-R155K).
The vectors pBGO-ATG-POU1 and pBGO-ATG-POU6 (34) were used
for introduction of mutations with QuickChange (Stratagene) following the instructions of the manufacturer (primers used for site-directed mutagenesis are available on request). All mutations were verified by
sequencing. The POU domain of zebra fish pou-2 was amplified by PCR
with zfpou2 DNA (10) as a template and the following two primers:
GGTGGATCCAGAGGAGACTCTGACTACTGAAG and
gccctaggccaaagctagacgtttcccttctg. The amplified POU domain was then
cloned into pBGO-ATG to give pBGO-ATG-zfpou2. OBF-1 was expressed
from the vector pBGO-ATG-OBF-1/9. For in vitro translation of all
pBGO vectors the TNT reticulocyte lysate kit (Promega) was used
following the instructions of the manufacturer. Reticulocyte lysate
translation reactions included [35S]Met. Equivalent
protein expression of the different mutant proteins was verified by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by
autoradiography and PhosphorImager quantification.
Unless otherwise specified EMSA reactions were performed as previously
described (
34) with a
32P-labeled 50-bp
SalI DNA fragment containing the octamer site
from the
intron Ig heavy chain
enhancer.
Transfection and luciferase assays.
All cDNAs to be
expressed in Drosophila cells were subcloned into pBD1119
(kindly supplied by E. Hafen, University of Zürich) after
KpnI-XbaI removal of green fluorescent protein.
In this plasmid cDNA expression is under the control of the
Drosophila
1-tubulin promoter. Oct-1 POU domains were
subcloned via KpnI-XbaI from the plasmid
pBGO-ATG-POU1 (wild type [wt]; L6A, E7A, or L6A-E7A) into pBD1119.
The mutation Oct-6-S6L-D7E was introduced into the Oct-6 cDNA
by PCR with the following primers: GCGGAATTCGGCATGGCCACCACCGCGCAG
(mOct6 cDNA start Met with
EcoRI),
ggcgaactgctccaggtcttcgaggctgggagcatcctcgtc
(mOct6 POU
S6L-D7E with
BbsI), CCCAGCCTCGAAGACCTGGAGCAGTTCGCCAAG
(mOct6 POU S6L-D7E with
BbsI), and
caggatatcgggtcactgcacagagccgggc
(mOct6 cDNA stop with
EcoRV).
The constructs for the POU
S and POU
H domains
were made by PCR with the following primers:
ACTCgaagacTGGAGGAGCCCAGTGACCTTG,
tcctggaga aGTCTTCtaacttgggctggagagggacg, TCCAgaagacGTGCCCTGAATTCTCCA
GG,
and ggtcccaccaGTCTTCtatgggttgattcttttttctttctgg. Amplified
fragments were cleaved with
BbsI, treated with T4 DNA
polymerase,
cloned into the vector pBGO-ATG cleaved with
NcoI and filled in
with T4 DNA polymerase. After
verification by sequencing they
were subcloned via
KpnI-
XbaI into pBD1119. All mutations were
verified by
sequencing.
The reporter plasmids 8xOcta-Luc and 8xOcta/mut-Luc are described
elsewhere.
Drosophila Schneider cells (SL2) were transfected as
previously described (
34). In brief, transfection with the
calcium-phosphate
coprecipitation was carried out by using 4 µg of
each plasmid
(reporter and expression vectors) 4 to 6 h after
plating of 10
7 cells/10-cm-diameter dish. In each sample,
the total amount of
expression vector DNA was kept constant by the
addition of pBD1119-empty,
and the total amount of DNA was brought to
20 µg with salmon sperm
DNA. Luciferase extracts were prepared
48 h after transfection,
and equivalent amounts of protein
(100 µg) were used for luciferase
assays.
Methylation interference assay and DNA backbone
modification.
Methylation interference assay was performed as
previously described (32) by using probes amplified by PCR
from the H2B promoter or from the Ig(
) light chain promoter. The
sequences of these probes were as follows: (top strand only): H2B,
GACACAAGACTTCAACTCTTCACCTTATTTGCATAAGCGATTCTATATAAAAGCGCCTTGTCATACCCT; Ig(
),
CCAATCCTAACTGCTTCTTAATAATTTGCATACCCTCACIGCATCGCCTTGGGGACTTCTTTA. Densitometric quantification of the autoradiographs was
performed with NIH Image version 1.5.
The phosphothioate-modified probes were synthesized by Ciba Basel or
Microsynth, based on the H2B probe used for the methylation
interference assay, and had the following sequence:
CGCTTATGCAAATAAGGTG,
accttatttgcataagcg.
 |
RESULTS |
Multiple positions in the DNA influence the formation of a
ternary complex with the POU domain and OBF-1.
To examine how
the POU domain/OBF-1 complex is assembled on DNA, we performed
methylation interference experiments. For this, two different probes
containing consensus octamer sites were partially methylated in vitro
with dimethyl sulfate and were used for preparative EMSA reactions with
the Oct-1 POU domain either alone or in the presence of OBF-1.
The various complexes were resolved by gel electrophoresis, and the
corresponding DNA was analyzed by chemical cleavage after elution. In
the presence of the POU domain a clear footprint was observed over the
octamer motif (compare lanes 3 and 8 with lanes 4 and 9 in Fig. 1A and
B) as expected; addition of OBF-1 did
not enlarge the footprint, nor did it modify the observed pattern
outside of the octamer site (Fig. 1A and B, lanes 5 and 10), in
agreement with data from chemical assays and recent DNase I footprint
(3, 27). Interestingly, on the two probes used, the octamer
site from the H2B or the Ig(
) promoter, the G at position +3 in the
sequence ATGCAAAT was found to be reproducibly underrepresented in the binary complex (POU/DNA; compare lanes 8 and 9 in Fig. 1A and B) and even more so in the ternary complex (compare lane
9 with lane 10 in Fig. 1A and B), indicating that methylation of this
position interferes with binding of the POU domain and of OBF-1.
The densitometric quantification of these primary results presented in
the lower part of Fig. 1 shows that position +3 was about 10-fold
reduced selectively in the presence of OBF-1. This position of the
octamer site is known from the cocrystal studies of Klemm et
al. (16) to interact directly with Arg 49 of the Oct-1
POUS. By contrast, the other positions of the octamer site
examined by methylation interference were either not selectively
altered in the presence of OBF-1 or were altered only with the H2B
probe (e.g., the G at position 4 on the lower strand).

View larger version (67K):
[in this window]
[in a new window]
|
FIG. 1.
Methylation interference assay showing an altered
pattern in the presence of OBF-1. End-labeled DNA probes containing
the octamer site from the Ig( ) light chain promoter (A) or from the
histone H2B promoter (B) were used to perform a methylation
interference assay with in vitro-translated Oct-1 POU domain and
OBF-1. After preparative EMSA the DNA present in the different
complexes was eluted, subjected to chemical cleavage, and displayed on
a sequencing gel. The products of G and G plus A sequencing reactions
of the probes were loaded in lanes 1, 2, 6, and 7. Lanes 3 and 8 contain DNA corresponding to the free probe, lanes 4 and 9 contain DNA
present in the POU domain complex, and lanes 5 and 10 contain DNA
present in the ternary complex. Lanes 1 through 5, top strand; lanes 6 through 10, bottom strand (for the sequences of the probes used see the
Materials and Methods section). The position of the octamer site is
boxed in the G plus A lane and schematically indicated by the gray box
on the side of the gel (panels A and B). For the H2B probe (panel B)
the open rectangle represents the TATA box that was also present in the
probe used. The lower part of the figure shows a densitometric
quantification of the bands corresponding to the guanines and adenines
of either strand of the octamer site in the above gels. The relative
intensity (ri) of the bands was plotted for the free DNA (white bars)
or for the DNA present in a complex with the POU domain alone (hatched
bars) or with the POU domain and OBF-1 (black bars). The arrows
point to the strong reduction in intensity of the methylated guanine at
position +3 in the complex with OBF-1. For simplicity the octamer
sequence is written throughout this paper in the orientation
5'-ATGCAAAT-3', even though for both the Ig( ) and H2B
promoters this corresponds to the sequence of the lower strand.
|
|
We next looked at the potential influence of the DNA backbone on
ternary complex formation and designed a number of
phosphothioate-modified
probes which, on the basis of the
Oct-1 POU/DNA cocrystal, should
not interfere with
binding of the Oct-1 POU domain. These probes
were
assayed by EMSA and compared with the unmodified probe (Fig.
2A). By quantification of the amount of
probe present in the different
complexes, we assessed the effects of
these modifications. As
shown in the quantification presented in Fig.
2B, modification
of the phosphate groups at the sense strand positions
p4 and p5
(lanes 2 and 1 in Fig.
2A) slightly increased ternary complex
formation. Likewise, modification of the phosphate groups at the
antisense strand positions

p7,

p8, and

p9 (Fig.
2A, lanes 7,
6, and 5) also increased ternary complex formation, while modification
of

p6 (Fig.
2A, lane 8) almost completely eliminated binding
of
OBF-1 without interfering with binding of the POU domain.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 2.
Modifications of the DNA backbone within the
octamer motif with phosphothioate groups influence ternary complex
formation. Oligonucleotides were synthesized with specific backbone
phosphate groups replaced by phosphothioate groups (positions p3, p4,
and p5 on the top strand and positions p6, p7, p8, and p9
on the bottom strand; see panel E for a diagram and the Materials and
Methods section for the complete sequences of the probes). These
modified probes were then tested by EMSA. (A) Autoradiograph from a
representative EMSA performed with the Oct-1 POU domain (lanes 1 to
8), OBF-1 (lanes 1 to 8), and modified (lanes 1 to 3 and 5 to 8) or
unmodified (lane 4) DNA probes. The position of the modification within
the octamer sequence (p5, p4, p3, p9, p8, p7, p6) is
indicated on the right of the autoradiograph. The unmodified DNA probe
is indicated by wt. All lanes contained equal amounts of OBF-1 and POU
domain. (b) Quantification by PhosphorImager of the amounts of probe
present in the different complexes on the basis of five independent
experiments. Open bars, POU/DNA complex; solid bars, Oct-1 POU domain
(lanes 2 to 5, 7 to 10, 12 to 15, and 17 to 20), and unmodified (lanes
1 to 5) or modified (lanes 6 to 20) DNA probes, as indicated. (D)
representative EMSA performed with a constant excess of the Oct-1 POU
domain (lanes 21 to 40), increasing amounts of OBF-1 (lanes 22 to 25, 27 to 30, 32 to 35, and 37 to 40), and unmodified (lanes 21 to 25) or
modified (lanes 26 to 40) DNA probes, as indicated. (E) Sequence of the
central part of the probe with circles indicating the modified
positions. , positions which when modified increase ternary complex
formation; , position which when modified reduce ternary complex
formation; , position which when modified is neutral.
|
|
To rule out the possibility that the observed effects might merely
reflect an altered interaction between the POU domain and
the DNA due
to some of the backbone modifications, these experiments
were repeated
either in the complete absence of OBF-1 (data not
shown) or under
conditions where the amount of one protein (POU
domain or OBF-1)
was kept constant and the other protein (OBF-1
or POU domain) was
titrated at increasing concentrations (Fig.
2C and D). As shown in Fig.
2C and D, the previously observed
effects, for example the disruption
of ternary complex formation
in the presence of the

p6
phosphothioate modification, were entirely
retained under both sets of
conditions, indicating that these
effects are not concentration
dependent. In addition, in EMSAs
done without OBF-1 it was clear
that the various probes were equally
well bound by the POU domain (data
not shown) (see also Fig.
2A,
C, and D). These data thus indicate that
OBF-1 indeed interacts
with several positions in the octamer
sequence, both in the major
groove, in particular on position +5 and as
shown recently (
3)
on position +6, and on the backbone, as
shown here. Furthermore,
by using bromodeoxyuridine-substituted
oligonucleotides, we could
show that OBF-1 can be UV
cross-linked to the cognate sequence,
both in a ternary complex with
the POU domain and also weakly
by itself (data not
shown).
OBF-1 interacts with the POU domain through residues both in
the POUS and the POUH.
To identify which
part(s) of the POU domain is necessary for selective interaction with
OBF-1, we used Oct-1/Pit-1 POU domain chimeras (2)
and assayed by EMSA their capacity to allow ternary complex
formation (for details, see the legend for Fig.
3). This approach was chosen because the
Pit-1 POU domain binds efficiently to the octamer motif, as a monomer
like POU1, but does not interact with OBF-1 (Fig. 3, lane 3). When
only the POU domain linker region was exchanged in POU1 the
ternary complex formation was unaffected (lane 6). However, when the
POUS domain was swapped the ternary complex formation was
either abolished completely (lane 4) or greatly reduced when only the
most N-terminal part of the POUS was exchanged
(POUSA subdomain; lane 8). By contrast, exchange of the
POUH did not completely abolish complex formation, although it significantly reduced it (lane 7). Together, these data indicate that both the POUS and the POUH are important
for complex formation with OBF-1 and that the major contribution
appears to come from the POUS, in particular from the
POUSA subdomain. Recently, similar experiments that are in
good agreement with our results were reported (3).

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 3.
Formation of a complex among Oct-1/Pit-1 chimeras,
OBF-1, and octamer site DNA is influenced by the origin of both the
POUS and the POUH. In vitro-translated proteins
were assayed by EMSA for their ability to interact by using an
octamer-containing DNA probe. The four-letter nomenclature
(2) beside the schematic representations of the POU domains
reflects the structures of the chimeras: the first two capital letters
indicate the origin of the POUSA and the POUSB,
respectively, the third, lowercase letter symbolizes the POU linker,
and the fourth, uppercase letter denotes the POUH domain. O
or o, Oct-1; P or p, Pit-1. All reaction mixtures contained equal
amounts of OBF-1 protein (lanes 2 through 9) or of POU domain
(lanes 1 through 9). For the exact sequences, see Fig. 7.
|
|
Two residues at the very beginning of the first helix of the
Oct-1 POUS are crucial for interaction with OBF-1
in vitro and in vivo.
To identify the residues in the
POUS domain that are critical for ternary complex
formation, we substituted amino acids at several positions
with alanine residues. We chose residues that differ in Oct-1 and
Pit-1 and are solvent accessible based on the Oct-1 POU-DNA
cocrystal (16) (see Fig. 7 and 9). As shown in
Fig. 4A, all substitutions tested
(D5A, T15A, G28A, M34A, K36A, D41A, N54A, N72A, and D73A) left
the ternary complex formation unchanged with the exceptions of L6A and
E7A (lanes 3 and 4), both of which reside in the beginning of the first
helix of the POUSA subdomain. The double substitution
L6A-E7A totally abolished OBF-1 binding activity in vitro (data not
shown) (see below). To confirm the importance of these two residues in
mediating interaction between OBF-1 and the POU domain, we set up
an in vivo assay. For this we used Drosophila SL2 cells
that, based on EMSAs or transfection experiments, do not contain any
Oct or OBF-1 protein (not shown) (see Fig. 4C) and therefore allow
us to test interactions in vivo without interference from
endogenous proteins. In initial experiments we found that, in
this system, transactivation of an octamer-containing reporter plasmid
required the simultaneous expression of Oct factors (e.g., Oct-1 or
Oct-2) and OBF-1, suggesting that the activation domains of
Oct-1 and Oct-2 that had been previously identified through
experiments done in mammalian cells (7, 22, 35, 36) are
inactive in these Drosophila cells. In agreement with this,
we found that the isolated POU domain was able to mediate activation of
the reporter plasmid essentially as efficiently as the complete
Oct-1 or Oct-2, provided OBF-1 was present (data not shown)
(see below). As shown in Fig. 4B, the wt Oct-1 POU domain mediated
a strong transactivation of the reporter plasmid by OBF-1; mutation
of either position 6 or position 7 (POU1-L6A or POU1-E7A) strongly
reduced activation, and substitution of both residues simultaneously
completely eliminated in vivo recruitment of OBF-1 by the POU
domain. As shown in the inset on the right of Fig. 4B, the different
POU domains were expressed equally well.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 4.
Two residues at the very beginning of the
POUS domain are essential for interaction with OBF-1 in
vitro and in vivo. (A) In vitro-translated proteins with alanine
substitutions in the POU specific moiety of the Oct-1 POU domain
were assayed for interaction with OBF-1 by EMSA as indicated in
Fig. 3. The scheme below the autoradiograph indicates the first and
last amino acids of the two POU specific domains. (B)
Drosophila SL2 cells were cotransfected with an
octamer-containing luciferase reporter plasmid together with an
Oct-1 POU domain expression vector in the absence (white bars) or
in the presence (hatched bars) of an OBF-1 expression vector. On
the left the relative luminescence (rlu) obtained with equal protein
amounts is indicated for one representative experiment among several
that gave similar results. Expression of the different POU domains was
tested by EMSA with cellular extracts from the transfected cells and
found to be identical, as shown in the inset presented on the right.
Only the part of the gel corresponding to the POU/DNA complex is shown. + or for OBF-1 indicates whether the extract originates
from a transfection containing or lacking OBF-1, respectively. (C)
In vitro-translated proteins with exchanges of the Pit-1 residues for
their Oct-1 counterparts in the context of the chimeras OOoO, POoO,
and PPoO were assayed for OBF-1 binding activity by EMSA. The
chimera used and the substitution introduced are indicated to the right
of each lane.
|
|
To further confirm the importance of residues 6 and 7 of the
POU
S, we subsequently also exchanged them with their
Oct-1 counterparts
individually or in combination in the two
chimeras POoO and PPoO
and tested complex formation in vitro by EMSA.
As shown in Fig.
4C, in either context the protein with the
substitution R7E showed
a larger gain of ternary complex formation than
that with I6L,
and the double substitution I6L-R7E showed a synergistic
effect
in both chimeras (Fig.
4C, lanes 7 and 9). In addition, these
results indicate that the effect is not dependent on the DNA binding
helix of the POU
S, since it is observed with both chimeras
P
OoO
and P
PoO (DNA binding helix underlined).
Together, these results
all support the initial finding that the
POU
SA subdomain contains
key determinants for the
selectivity of interaction with OBF-1,
but that additional residues
in the POU
H are also required (see
below).
Two residues in the third, DNA recognition helix of the Oct-1
POU homeodomain interact specifically with OBF-1.
From the analysis with the Oct-1/Pit-1 chimeras it is apparent that
the chimera OOoP shows a much-reduced affinity for OBF-1 when
compared to OOoO, indicating that the homeodomain also
plays an important role for interaction with OBF-1 (Fig. 3). To
identify the critical position(s) we replaced with alanine the residues of the Oct-1 POU homeodomain that differ in Oct-1
and Pit-1, are solvent accessible, and lie roughly on the same face of
the POU1/DNA cocrystal relative to the already identified
positions in the POUS and on the DNA (see also Fig. 9). The
substitutions in the first candidate region we looked at (S107, E109,
T110, N111, R113, and V114) did not produce any effect (data not shown)
(see Fig. 7 and 9). By contrast, substitutions at two positions in the
second candidate region produced a distinct effect (I159A) or a weak effect (K155A; Fig. 5, lanes 3 and 2),
while substitutions at two other positions had no effect (N160A and
P161A; Fig. 5, lanes 4 and 5). When tested in the absence of OBF-1
all these mutant POU domains were found to bind equally well to the
probe (data not shown), indicating that the reduction in interaction
with OBF-1 did not reflect a reduced DNA binding capacity. To
further analyze this, the Oct-1 counterparts of these different
residues were introduced individually or in combinations into the OOoP chimera, which interacted only weakly with OBF-1 (Fig. 3). When the
substitution R155K was present (Fig. 5, lanes 7, 11, and 13) a clear
gain of ternary complex formation was always detected. These data
suggest that of the positions tested in the POUH, positions 155 and 159 are the most important for interaction with OBF-1, although their relative context appears to play a role (OOoO versus OOoP). Similar conclusions were also obtained in a very recent study,
where it was shown that the POUH positions K155 and I159 as
well as the conserved positions N151 and R158 are critical for
interaction with OBF-1 (3).

View larger version (84K):
[in this window]
[in a new window]
|
FIG. 5.
Residues at the end of the POUH are critical
for interaction with OBF-1. In vitro-translated proteins with
alanine substitutions in the POU homeodomain of Oct-1
were assayed for OBF-1 binding activity by EMSA (lanes 1 through
5). In the Oct-1/Pit-1 POU domain chimera OOoP amino acids were
exchanged individually (lanes 7 to 10) or in combination (lanes 11 to
13) for their Oct-1 counterparts. The substitution(s) introduced
and its position(s) are indicated at the right of the figure. In the
case of multiple substitutions only the introduced amino acids are
indicated (lanes 11 to 13), and their positions correspond to those in
lanes 7 to 10. Lane 14 contains only the probe.
|
|
Other members of the POU family can interact with OBF-1.
Based on the above results we made predictions about the minimal
requirements for a POU domain to interact with OBF-1. The POU
domain should be bound to a permissive DNA binding site (e.g., A at
positions +5 and +6), and there should be either a leucine at position
6 or a glutamate at position 7 of the POUS or both, depending on the context (Oct-1 versus Pit-1 POUS
surface composition); in addition, in the POUH positions
155 and 159 also play a critical role depending on the context
(Oct-1 versus Pit-1 POUH surface composition). We
looked for POU family members fulfilling all or part of these criteria
and first tested the zebra fish pou-2 (10) POU domain. The
POU domain of zebra fish pou-2 has positions E7 and K155 conserved and
a divergent position T6 compared with Oct-1 (see Fig. 7). However,
this POU domain showed OBF-1 binding activity comparable to that of
the Oct-1 POU domain (Fig. 6A, lane
7). Thus, it seems that the negative charge of E7 is sufficient to
allow interaction with OBF-1 and that in this context the divergent position T6 is not critical.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 6.
Interaction between OBF-1 and the POU domain of
other POU family members. (A) In vitro-translated proteins assayed for
OBF-1 binding activity by EMSA. Oct-1 POU domain (lanes 1 and
2), Oct-6 POU domain or derivatives thereof (lanes 3 to 6), and
zebra fish pou-2 (zfpou2) POU domain (lanes 7 and 8). For Oct-6 POU
the amino acids substituted with their Oct-1 counterparts are
indicated to the right of each lane (lanes 4 to 6). (B)
Transient-transfection assay in Drosophila SL2 cells. A
luciferase reporter under the control of wt (solid bars) or mutated
(open bars) octamer sites was introduced into SL2 cells together with
an empty expression vector (lanes 1 and 2) or a vector expressing
Oct-1 (lanes 3 and 4), Oct-6 (lanes 5 and 6) or
Oct-6-S6L/D7E (lanes 7 and 8). Even-numbered lanes also contained
an expression vector for OBF-1. The total amounts of
expression vector in the different samples were equalized by the
addition of empty vector. Forty-eight hours after DNA addition an
aliquot of each sample was processed for luciferase assays (upper part
panel B) and the rest was used for preparation of a whole-cell extract
followed by EMSA with an octamer site probe to control for protein
expression (lower part of panel B; only the part of the gel comprising
the Oct protein/DNA complex is shown).
|
|
We have previously shown that neither the Oct-4 nor the Oct-6
POU domain interacts with OBF-1 in vitro (
34). In the
case
of Oct-6, while position K155 in the POU
H is
conserved, positions
6 and 7 in the POU
S domain are
divergent from the corresponding
positions in Oct-1 (Fig.
7). We therefore substituted these two
divergent positions with their Oct-1 counterparts individually
or
in combination and tested the capacity of the resulting proteins
to
interact with OBF-1 in vitro. As shown in Fig.
6A, POU6-S6L
interacted efficiently with OBF-1, while POU6-D7E did not (lanes
3 to 5); yet, the double substitution POU6-S6L-D7E showed a synergistic
effect and allowed very efficient ternary complex formation (lane
6).
To substantiate these findings in vivo, we introduced the
above-mentioned double amino acid changes into full-length Oct-6
to
create Oct-6-S6L-D7E and tested whether this protein was responsive
to OBF-1 in a transient-transfection assay done in SL2 cells.
For
these experiments we cotransfected a reporter plasmid under
the control
of multiple octamer sites (wt or mutated) as well
as expression
vectors for Oct-1, Oct-6 wt, or Oct-6-S6L-D7E, with
or
without an OBF-1 expression vector. As described above, on
their
own none of the tested Oct factors activated the reporter
plasmid
(Fig.
6B), in spite of the fact that they were efficiently
expressed in
transfected cells, as shown at the bottom of Fig.
6B. However,
when OBF-1 was cotransfected with Oct-1 the reporter
was
activated approximately 14-fold, and when it was cotransfected
with
Oct-6-S6L-D7E the reporter was activated about 15-fold. In
contrast
to what was anticipated based on the in vitro results,
in SL2 cells
cotransfection of Oct-6 wt together with OBF-1 also
activated
the reporter, but only ca. sixfold. Although no interaction
had been
detected with OBF-1 in vitro, either with the isolated
POU domain
(Fig.
6A) or with the full-length Oct-6 protein (data
not shown),
it is conceivable and supported by our data that Oct-6
may have a
weak potential for interaction which, however, was
not detected under
stringent EMSA conditions. However, it is clear
that changing the amino
acids at positions 6 and 7 in the Oct-6
POUS domain to their
Oct-1 counterparts results in a protein that
in vivo activates in
the presence of OBF-1 better than the wt
protein, most likely
reflecting enhanced recruitment of this coactivator.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 7.
Alignment of the POU domains used in this study. The
Oct-1 POU domain sequence was chosen as a reference to which the
other sequences were compared. Identical positions are indicated with a
dot, and at divergent positions the amino acid is indicated. Above the
sequences the borders of the regions A and B and the helices (I
through IV) are indicated, as well as the numbering of the amino acids.
The asterisk above the sequence for the POU1 linker shows the position
at which the POU domain was separated into two halves for the
experiment presented in Fig. 8. At the bottom the sequence of Oct-1
is displayed again with the residues examined in this study and
critical for interaction with OBF-1 indicated by solid arrows;
residues that were mutated and did not interfere with OBF-1 binding
are indicated by open arrows. Squares and circles indicate POU domain
residues identified in other studies (3, 8) that, when
mutated, disrupted (solid symbols) or did not disrupt (open symbols)
association with OBF-1.
|
|
In vivo OBF-1 can clamp artificially separated moieties of the
POU domain on the DNA and thereby activate a reporter gene.
The
data presented in this paper indicate that OBF-1 interacts with the
POU domain by making selective contacts with specific residues in both
the POUS and the POUH and also by touching
several positions in the major groove and on the backbone of the
octamer site. Thereby, OBF-1 appears to close the protein ring
around the DNA, as the POU domain itself already surrounds the DNA on three sides: from the top (POUS), from the bottom
(POUH), and from the back (POU linker; see Fig. 9). We
therefore wondered whether OBF-1 might be able to tether to the DNA
a POU domain that has been artificially separated into two halves in
the middle of the linker. For this we expressed in SL2 cells the
POUS and/or the POUH separately, in the
presence or in the absence of OBF-1, and measured transactivation
of the reporter plasmid. As shown in Fig.
8, when either of the POU domain moieties
was expressed by itself, inclusion of OBF-1 in the transfection had
no effect and no transactivation was observed. By contrast, when both
the POUS and the POUH were coexpressed
from
separate plasmids
addition of OBF-1 led to strong transactivation
of the reporter plasmid, to a level at least equal to that obtained
with the intact POU domain. These data strikingly demonstrate that for
the formation of a ternary complex on DNA OBF-1 requires both
moieties of the POU domain and further suggest that OBF-1 may have
the capacity to tether the POU domain on the DNA, perhaps stabilizing
it.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 8.
In vivo OBF-1 can recruit artificially separated
halves of the POU domain to the DNA. (A) Drosophila SL2
cells were transiently transfected with an octamer-containing
luciferase reporter plasmid and expression vectors encoding the entire
Oct-1 POU domain, or its individual domains POUS and
POUH, in the presence (hatched bars) or in the absence
(open bars) of an OBF-1 expression vector, as indicated. Solid bars
represent transfections performed with the same expression vectors but
with a reporter plasmid containing mutated octamer sites. The figure
shows the relative luminescence (rlu) obtained in a representative
experiment among several that gave similar results. (B) Schematic
representation of the POU domain derivatives used for these
experiments.
|
|
 |
DISCUSSION |
In this study we have investigated the requirements for a POU
domain to selectively interact with OBF-1 by analyzing parameters in the DNA and in the protein.
We assayed the footprint of OBF-1 in the ternary complex by a
methylation interference assay and found that methylation of the
guanine at position +3 of the octamer site (ATGCAAAT)
interferes with OBF-1 binding. Furthermore, we modified the
DNA backbone with phosphothioate groups and analyzed the effect on
ternary complex formation. This procedure identified several positions on both DNA strands that influence interaction with OBF-1 when modified. In the Oct-1 POU domain, using amino acid
substitutions, we identified several residues in the POUS
(L6 and E7) and the POUH (K155 and I159) that are crucial
for interaction with OBF-1 in vitro and also in vivo. Thus, in
contrast to the other POU-domain-interacting proteins like VP16 and
SNAPc/PTF, OBF-1 selectively interacts with both the
POUS and the POUH as well as with the DNA.
Strikingly, we found that in vivo OBF-1 is capable of
recruiting separated POU domains to the promoter DNA, thereby
leading to transcriptional activation of the reporter gene. This
genetically demonstrates that OBF-1 needs to interact with both
moieties of the POU domain and supports the notion that this
coactivator may stabilize the POU domain on the DNA.
Ternary complex formation is influenced by a number of specific and
nonspecific DNA determinants.
So far for formation of a ternary
complex no sequence requirements have been identified outside the
octamer motif for OBF-1. However, within the octamer
motif multiple positions are important. The base pair at position +5
(ATGCAAAT) has been identified earlier as being
essential for interaction with OBF-1 (4, 8), and recently position +6 and, to a lesser extent, positions +3 and +4 have
also been found to be important (3). Here we showed by a
different technique, methylation interference, that the
guanine residue at position +3 is critical for the formation of a
complex containing OBF-1.
Furthermore, by introducing phosphothioate modifications at various
positions in the DNA backbone, we could show that several
of these
positions also modulate ternary complex formation, indicating
that they
are in close proximity of OBF-1. In particular, backbone
position
p6, when modified with a phosphothioate, completely disrupted
interaction with OBF-1 without affecting the interaction with
the
POU domain. Interestingly, the identified backbone positions
lay
spatially between the critical residues identified in the
POU
S (positions 6 and 7) and the POU
H
(positions 155 and 159)
(see below and Fig.
9). In addition, these backbone positions
flank the major groove where the reactive groups of the identified
bases at positions +3, +4, +5, and +6 are located. These data
suggest
that OBF-1 lies over this region in the major groove and
makes
interactions with several bases as well as with the backbone
crests.
The hydroxyl radical footprints performed by Verrijzer
et al. (
37,
39) examining the interaction between the POU
domain and the DNA
showed an unprotected deoxyribose window between
positions
+2 and +4 on the sense strand (ATGCAAAT) and at
position
+8 on the antisense strand (TACGTTTA). This window
seems to be
partially filled by OBF-1, since phosphothioates at
positions
+p4 and +p5 on the sense strand
(ATG
pCpAAAT) and positions

p7,

p8, and

p9 on the antisense strand (TACGTT
TpApTp) increase
ternary
complex formation. It had been shown earlier that at a
very high
concentration the N-terminal amino acids 1 to 118 of
OBF-1 can
interact with the octamer site even in the absence of POU
domain
(
4), and in line with this, we were able to
cross-link with
UV OBF-1 to a bromodeoxyuridine-substituted octamer
probe (data
not shown). Recently, by a DNase I footprint assay done
with an
artificial probe consisting of an Ig(

) octamer close to an
H2B
octamer, it was shown that OBF-1 can stabilize the POU domain
on the DNA (
3), albeit weakly. Yet, in earlier experiments
done by EMSA on single-site probes, OBF-1 was found neither to
increase the on rate of POU domain binding to the DNA nor to decrease
its off rate (
34).

View larger version (52K):
[in this window]
[in a new window]
|
FIG. 9.
Model of the interaction surface between the POU
domain/DNA complex and OBF-1 highlighting the positions identified
in this study. The modeling program Insight II was used to generate
this picture by using the coordinates of the Oct-1 POU
domain/octamer motif cocrystal (16). Panels A and C
represent 90° counterclockwise or clockwise rotations along the
vertical axis of the projection presented in projection B. The octamer
sequence DNA ATGCAAT is displayed in magenta. Backbone
positions enhancing or eliminating association with OBF-1 when
modified with a phosphothioate group are represented by green (p4, p5,
p7, p8 and p9) or red (p6) balls, respectively. Blue balls represent
the backbone position p3 that was found not to influence interaction
with OBF-1. The position of the methyl group on G at position +3
that interferes with OBF-1 binding is indicated by a red ball to
which an arrow points. The two central base pairs at positions +5 and
+6 important for OBF-1 binding are represented thicker. The POU
domain is displayed in white. Residues whose substitution by alanine
eliminated interaction with OBF-1 are indicated in red, and
residues whose substitution by alanine did not interfere with OBF-1
association are depicted in blue. The POU linker that connects both
domains together is not visible in the crystal, but should be imagined
to pass on the left of the DNA in projection A or in the back of
projection B.
|
|
Structure of the POU domain on the DNA.
For our analysis we
assumed that the POU domains of Oct-1 and Pit-1 as well as the
chimeras thereof bind as a monomer in a roughly similar conformation to
the octamer-site probe used for the EMSAs. In the cocrystal of
POU1 bound to DNA (octamer site), the POU domain binds as a monomer
interacting with opposite faces of the DNA (16); by
contrast, in the recently described cocrystal of the Pit-1 POU
domain bound to DNA (prolactin gene promoter-derived site), the POU
domain binds as a dimer with each POU domain binding to one face of the
DNA only (13), thus revealing surprisingly different overall
arrangements of the POU domain in the two crystals. Yet, the
conformations of the individual POU domain subunits (POUS and POUH) regarded on their own appear to be very similar
in the two cocrystals. Clearly, the nature of the DNA site
appears to be of crucial importance in defining the
overall spatial arrangement of a POU domain bound to DNA. When we
compared the Pit-1 POU domain and the chimera PPoO (containing
only the POUS domain from Pit-1) on different probes,
we found that these proteins indeed bind as a dimer on a prolactin
promoter probe but as a monomer on an octamer probe; on the other hand,
POU1 bound as a monomer on either of these probes (data not shown).
Thus, on the basis of these considerations it can be assumed that Pit-1
POU binds to the octamer site in a conformation similar to that of
POU1; this is further supported by the finding that the chimera
PPoO/6L7E recruits OBF-1 efficiently (Fig. 4C).
Multiple residues in the POUS and the POUH
mediate interaction with OBF-1.
Using Pit-1/Oct-1 POU
domain chimeras, we found that the POUS and the
POUH both contribute to association with OBF-1, and other recent experiments are in agreement with this (3). On the basis of these results we tested by mutation amino acids that were
different in Pit-1 and Oct-1 and that are deemed to be located on
the surface of the POU domain based on the available crystallographic data. We found that mutation with change to alanine at position L6 or
E7 in the Oct-1 POUS was sufficient to severely disrupt in vitro association with OBF-1 (Fig. 3) and that mutation of both
residues completely abolished the interaction. In addition, these
findings could be entirely recapitulated in an in vivo transactivation assay in which wt or mutant POU1 domains were used to recruit OBF-1
to the promoter of a reporter gene. Finally, introduction of the
Oct-1 amino acids at the corresponding positions in the POoO or
PPoO chimeras resulted by and large in the expected increase in
association with OBF-1.
In addition to positions 6 and 7, which are divergent among different
POU domains, the conserved positions E9, L10, R49, L53,
L55, S56, N59,
and M60 have recently been found to be critical
for association between
the POU1 domain and OBF-1 (
3). By contrast,
several
other conserved residues (e.g., Q11, K17, F57, K58, or
K64)
(
3) as well as nonconserved residues (e.g., D5, E8, K14,
T15, D29, M34, K36, or D41, examined here) can be mutated with
change
to alanine without deleterious effect on the interaction
with OBF-1
(summarized in Fig.
7; see also Fig.
9). Thus, it appears
that in the
POU
S OBF-1 requires a number of residues for
interaction
but discriminates between a permissive (e.g., Oct-1)
and a nonpermissive
(e.g., Pit-1) POU domain on the basis of only two
residues at
the very beginning of the first
helix.
A somewhat similar situation was found for the selective interactions
between OBF-1 and the POU
H. Results from this study
as
well as data from the report by Babb et al. (
3) demonstrated
that replacement with alanine of several conserved (e.g., E118,
E130,
or R152) or nonconserved amino acids (e.g., T107, E109,
T110, N111,
R113, V114, N160, or P161) does not disrupt association
with OBF-1.
By contrast, a few residues at the end of the third
POU
H

-helix, in particular K155 and I159, and also the conserved
N151 and
R158 (
3) are essential, as shown above. In the context
of
the chimera OOoP we found only position 155 to produce a significant
increase in association with OBF-1 when substituted with its
Oct-1
counterpart (R155K) (see Fig.
5,
7, and
9).
A reason that could account for this effect is the unraveled tertiary
structure found in the third helix of the POU1
H and
POU2
H (
16,
33). Even though conserved at the
level of primary
structure, the last four residues of this helix in the
two proteins
show a tertiary structure divergence. The same unraveled
tertiary
structure in the C-terminal region of the third helix is also
found in the Pit-1 POU
H domain (in addition to a divergence
in
primary structure) (
13).
Given these findings, it appears that most, if not all, of the
selectivity of interaction with OBF-1 rests with the few POU
domain
residues that were identified here: L6, E7, K155, and I159.
This was
further confirmed by showing that zebra fish pou-2, which
fulfills most of the above-mentioned criteria, does indeed
associate
efficiently with OBF-1. In addition, we demonstrated that
Oct-6
can interact well with OBF-1 in vitro, provided
positions 6 and
7 are converted to their Oct-1
counterparts.
Requirement for VP16 and SNAPc to interact with the POU
domain.
Specific interaction of the POU domain on the octamer with
the two transcriptional coactivators VP16 and SNAPc has already been
precisely described. The herpes simplex virus protein VP16 has been
shown to discriminate Oct-1 from Oct-2 through position 22 in
the POUH domain (Glu for POU1 versus Ala for POU2). In
addition, for efficient complex formation VP16 requires a conserved
DNA-flanking region adjacent to the octamer motif as well as a host
cell factor.
It has been shown recently that the RNA Pol II- and Pol III-specific
coactivator SNAPc/PTF interacts with the POU1
S residue
E7
(
21) through the SNAP190 subunit (
41). It is
interesting
that position E7 of the POU
S is the sole
crucial binding determinant
identified for interaction with SNAP190,
and indeed SNAP190 shows
a weak homology to the region in the N
terminus of OBF-1 that
interacts with the POU domain. Both VP16 and
SNAP190 interact
selectively with one residue of either the
POU
H or the POU
S, respectively.
By contrast,
OBF-1 interacts specifically with a number of residues
located in
both POU domain moieties, and it was shown recently
that OBF-1 and
VP16 can bind simultaneously to the POU domain
on the DNA
(
3).
OBF-1 can recruit artificially separated POU domain moieties to
the DNA.
The results presented in this study suggest that
OBF-1, contacting both moieties of the POU domain and closing the
protein ring around the DNA, may in part have a function equivalent to that of the POU linker in holding the POU domain together and possibly
stabilizing it on the octamer site. We therefore wondered whether
OBF-1 might help to recruit to the octamer site two artificially separated POU domain moieties. To test this hypothesis an in vivo transactivation assay was used, and we could show that the reporter plasmid was indeed efficiently activated when both POUS and
POUH as well as OBF-1 were present (Fig. 8). By
contrast, when only the POUS or the POUH was
present together with OBF-1, no activation was observed. This
result strongly suggests that in this setting OBF-1 in some way
replaces the POU linker and helps to recruit and stabilize the two POU
domain moieties on the DNA. Since OBF-1 carries a strong
transcription activation domain in its C-terminal part (8,
27), formation of the ternary complex then leads to activation of
the reporter plasmid. Babb et al. (3) also recently came to
the same conclusion on the basis of DNase I footprinting experiments as
well as in vivo transactivation by using a VP16-POU1 fusion protein
together with a truncated OBF-1 (amino acids 1 to 118) lacking the
transcription activation domain. This VP16-POU1 fusion protein did not
activate transcription by itself (surprisingly), but it did so in the
presence of the truncated OBF-1, suggesting that in this case
OBF-1 acted to stabilize the VP16-POU1 molecule on the DNA. We also
found that a similar VP16-POU1 fusion protein is indeed inactive in
vivo unless OBF-1 is present; in addition, we found that, unlike
POU1, this VP16-POU1 protein does not bind to DNA in an EMSA,
presumably due to some steric hindrance caused by VP16 (data not
shown). One can thus speculate that in this case also OBF-1 in some
way rearranges the POU domain such that DNA binding is rendered
possible in spite of the negative effect of VP16.
Taken together, all these findings suggest that the formation of a
ternary complex among the POU domain, OBF-1, and the DNA
is a
highly complex process in which each partner may influence
the other
two. Although the POU domain is clearly able to bind
to DNA by itself
and can be viewed as recruiting OBF-1, one can
also speculate that
OBF-1 in fact helps the POU domain to organize
itself on the DNA
and thereby stabilizes it. Such a coactivator
not only may thus play a
role at the level of transcription initiation
but also could, for
instance, help to form a stable transcription
complex locked on the DNA
and allowing multiple rounds of transcription
to take
place.
 |
ACKNOWLEDGMENTS |
We are grateful to Winship Herr (Cold Spring Harbor Laboratory)
for the POU domain chimeras, to Thomas Gerster (Biocenter, University
of Basel) for the zebra fish POU2 cDNA, to Hans Schöler (European
Molecular Biology Laboratory) for the Oct-6 cDNA, to Ernst Hafen
(University of Zürich) for the vector pBD1119, to Robert
Häner (Ciba Basel) for the DNA backbone modified probes, to Gabi
Matthias for help with plasmid constructions, and to Jan Hofsteenge for
instructions on how to use INSIGHT II. We thank the Matthias group for
inspiring and critical discussions and Brian Hemmings and Timothy Miles
for critically reading the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Friedrich
Miescher-Institute, Maulbeerstr. 66, P.O. Box 2543, CH-4058 Basel,
Switzerland. Phone: 41-61-697 66 61. Fax: 41-61-697 39 76. E-mail:
matthias{at}fmi.ch.
 |
REFERENCES |
| 1.
|
Assa-Munt, N.,
R. J. Mortishire-Smith,
R. Aurora,
W. Herr, and P. E. Wright.
1993.
The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain.
Cell
73:193-205[Medline].
|
| 2.
|
Aurora, R., and W. Herr.
1992.
Segments of the POU domain influence one another's DNA-binding specificity.
Mol. Cell. Biol.
12:455-467[Abstract/Free Full Text].
|
| 3.
|
Babb, R.,
M. A. Cleary, and W. Herr.
1997.
OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
Mol. Cell. Biol.
17:7295-7305[Abstract].
|
| 4.
|
Cepek, K. L.,
D. I. Chasman, and P. A. Sharp.
1996.
Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.
Genes Dev.
10:2079-2088[Abstract/Free Full Text].
|
| 5.
|
Clark, M. E., and P. L. Mellon.
1995.
The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer.
Mol. Cell. Biol.
15:6169-6177[Abstract].
|
| 6.
|
Dekker, N.,
M. Cox,
R. Boelens,
C. P. Verrijzer,
P. C. van der Vliet, and R. Kaptein.
1993.
Solution structure of the POU-specific DNA-binding domain of Oct-1.
Nature
362:852-855[Medline].
|
| 7.
|
Gerster, T.,
C. G. Balmaceda, and R. G. Roeder.
1990.
The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription.
EMBO J.
9:1635-1643[Medline].
|
| 8.
|
Gstaiger, M.,
O. Georgiev,
H. van Leeuwen,
P. van der Vliet, and W. Schaffner.
1996.
The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
EMBO J.
15:2781-2790[Medline].
|
| 9.
|
Gstaiger, M.,
L. Knoepfel,
O. Georgiev,
W. Schaffner, and C. M. Hovens.
1995.
A B-cell coactivator of octamer-binding transcription factors.
Nature
373:360-362[Medline].
|
| 10.
|
Hauptmann, G., and T. Gerster.
1995.
Pou-2 a zebra fish gene active during cleavage stages and in the early hindbrain.
Mech. Dev.
51:127-138[Medline].
|
| 11.
|
Herr, W., and M. A. Cleary.
1995.
The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain.
Genes Dev.
9:1679-1693[Free Full Text].
|
| 12.
|
Herr, W.,
R. A. Sturm,
R. G. Clerc,
L. M. Corcoran,
D. Baltimore,
P. A. Sharp,
H. A. Ingraham,
M. G. Rosenfeld,
M. Finney,
G. Ruvkun, and H. R. Horvitz.
1988.
The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2 and Caenorhabditis elegans unc-86 gene products.
Genes Dev.
2:1513-1516[Free Full Text].
|
| 13.
|
Jacobson, E. M.,
P. Li,
A. Leon-del-Rio,
M. G. Rosenfeld, and A. K. Aggarwal.
1997.
Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility.
Genes Dev.
11:198-212[Abstract/Free Full Text].
|
| 14.
|
Kim, U.,
X. F. Qin,
S. Gong,
S. Stevens,
Y. Luo,
M. Nussenzweig, and R. G. Roeder.
1996.
The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.
Nature
383:542-547[Medline].
|
| 15.
|
Kissinger, C. R.,
B. S. Liu,
E. Martin-Blanco,
T. B. Kornberg, and C. O. Pabo.
1990.
Crystal structure of an engrailed homeodomain-DNA complex at 2.8 Å resolution: a framework for understanding homeodomain-DNA interactions.
Cell
63:579-590[Medline].
|
| 16.
|
Klemm, J. D.,
M. A. Rould,
R. Aurora,
W. Herr, and C. O. Pabo.
1994.
Crystal structure of the Oct-1 POU domain bound to an octamer site: DNA recognition with tethered DNA-binding modules.
Cell
77:21-32[Medline].
|
| 17.
|
Kristie, T. M., and P. A. Sharp.
1993.
Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16).
J. Biol. Chem.
268:6525-6534[Abstract/Free Full Text].
|
| 18.
|
Lai, J. S.,
M. A. Cleary, and W. Herr.
1992.
A single amino acid exchange transfers VP16-induced positive control from the Oct-1 to the Oct-2 homeo-domain.
Genes Dev.
6:2058-2065[Abstract/Free Full Text].
|
| 19.
|
Luo, Y.,
H. Fujii,
T. Gerster, and R. G. Roeder.
1992.
A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.
Cell
71:231-241[Medline].
|
| 20.
|
Luo, Y., and R. G. Roeder.
1995.
Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B.
Mol. Cell. Biol.
15:4115-4124[Abstract].
|
| 21.
|
Mittal, V.,
M. A. Cleary,
W. Herr, and N. Hernandez.
1996.
The Oct-1 POU-specific domain can stimulate small nuclear RNA gene transcription by stabilizing the basal transcription complex SNAPc.
Mol. Cell. Biol.
16:1955-1965[Abstract].
|
| 22.
|
Müller-Immergluck, M. M.,
W. Schaffner, and P. Matthias.
1990.
Transcription factor Oct-2A contains functionally redundant activating domains and works selectively from a promoter but not from a remote enhancer position in non-lymphoid (HeLa) cells.
EMBO J.
9:1625-1634[Medline].
|
| 23.
|
Murphy, S.,
J. B. Yoon,
T. Gerster, and R. G. Roeder.
1992.
Oct-1 and Oct-2 potentiate functional interactions of a transcription factor with the proximal sequence element of small nuclear RNA genes.
Mol. Cell. Biol.
12:3247-3261[Abstract/Free Full Text].
|
| 24.
|
Nielsen, P. J.,
O. Georgiev,
B. Lorenz, and W. Schaffner.
1996.
B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.
Eur. J. Immunol.
26:3214-3218[Medline].
|
| 25.
|
Otting, G.,
Y. Q. Qian,
M. Billeter,
M. Muller,
M. Affolter,
W. J. Gehring, and K. Wuthrich.
1990.
Protein-DNA contacts in the structure of a homeodomain-DNA complex determined by nuclear magnetic resonance spectroscopy in solution.
EMBO J.
9:3085-3092[Medline].
|
| 26.
|
Pabo, C. O.,
A. K. Aggarwal,
S. R. Jordan,
L. J. Beamer,
U. R. Obeysekare, and S. C. Harrison.
1990.
Conserved residues make similar contacts in two repressor-operator complexes.
Science
247:1210-1213[Abstract/Free Full Text].
|
| 27.
|
Pfisterer, P.,
S. Zwilling,
J. Hess, and T. Wirth.
1995.
Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
J. Biol. Chem.
270:29870-29880[Abstract/Free Full Text].
|
| 28.
|
Pomerantz, J. L.,
T. M. Kristie, and P. A. Sharp.
1992.
Recognition of the surface of a homeo domain protein.
Genes Dev.
6:2047-2057[Abstract/Free Full Text].
|
| 29.
|
Sauter, P., and P. Matthias.
1997.
The B cell-specific coactivator OBF-1 (OCA-B, Bob-1) is inducible in T cells and its expression is dispensable for IL-2 gene induction.
Immunobiology
197:293-302.
|
| 30.
|
Schubart, D. B.,
A. Rolink,
M. H. Kosco-Vilbois,
F. Botteri, and P. Matthias.
1996.
B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation.
Nature
383:538-542[Medline].
|
| 31.
|
Schubart, D. B.,
P. Sauter,
S. Massa,
E. M. Friedl,
H. Schwarzenbach, and P. Matthias.
1996.
Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.
Nucleic Acids Res.
24:1913-1920[Abstract/Free Full Text].
|
| 32.
|
Schwarzenbach, H.,
J. W. Newell, and P. Matthias.
1995.
Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters.
J. Biol. Chem.
270:898-907[Abstract/Free Full Text].
|
| 33.
|
Sivaraja, M.,
M. C. Botfield,
M. Mueller,
A. Jancso, and M. A. Weiss.
1994.
Solution structure of a POU-specific homeodomain: 3D-NMR studies of human B-cell transcription factor Oct-2.
Biochemistry
33:9845-9855[Medline].
|
| 34.
|
Strubin, M.,
J. W. Newell, and P. Matthias.
1995.
OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.
Cell
80:497-506[Medline].
|
| 35.
|
Tanaka, M., and W. Herr.
1990.
Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.
Cell
60:375-386[Medline].
|
| 36.
|
Tanaka, M.,
J. S. Lai, and W. Herr.
1992.
Promoter-selective activation domains in Oct-1 and Oct-2 direct differential activation of an snRNA and mRNA promoter.
Cell
68:755-767[Medline].
|
| 37.
|
Verrijzer, C. P.,
M. J. Alkema,
W. W. van Weperen,
H. C. Van Leeuwen,
M. J. Strating, and P. C. van der Vliet.
1992.
The DNA binding specificity of the bipartite POU domain and its subdomains.
EMBO J.
11:4993-5003[Medline].
|
| 38.
|
Verrijzer, C. P., and P. C. Van der Vliet.
1993.
POU domain transcription factors.
Biochim. Biophys. Acta
1173:1-21[Medline].
|
| 39.
|
Verrijzer, C. P.,
J. A. van Oosterhout,
W. W. van Weperen, and P. C. van der Vliet.
1991.
POU proteins bend DNA via the POU-specific domain.
EMBO J.
10:3007-3014[Medline].
|
| 40.
|
Wilson, A. C.,
K. LaMarco,
M. G. Peterson, and W. Herr.
1993.
The VP16 accessory protein HCF is a family of polypeptides processed from a large precursor protein.
Cell
74:115-125[Medline].
|
| 41.
|
Wong, M. W.,
R. W. Henry,
B. Ma,
R. Kobayashi,
N. Klages,
P. Matthias,
M. Strubin, and N. Hernandez.
1998.
The large subunit of basal transcription factor SNAPc is a Myb domain protein that interacts with Oct-1.
Mol. Cell. Biol.
18:368-377[Abstract/Free Full Text].
|
| 42.
|
Zwilling, S.,
A. Dieckmann,
P. Pfisterer,
P. Angel, and T. Wirth.
1997.
Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells.
Science
277:221-225[Abstract/Free Full Text].
|
Molecular and Cellular Biology, December 1998, p. 7397-7409, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Ushmorov, A., Ritz, O., Hummel, M., Leithauser, F., Moller, P., Stein, H., Wirth, T.
(2004). Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood
104: 3326-3334
[Abstract]
[Full Text]
-
Laumen, H., Brunner, C., Greiner, A., Wirth, T.
(2004). Myosin light chain 1 atrial isoform (MLC1A) is expressed in pre-B cells under control of the BOB.1/OBF.1 coactivator. Nucleic Acids Res
32: 1577-1583
[Abstract]
[Full Text]
-
Sepulveda, M. A., Emelyanov, A. V., Birshtein, B. K.
(2004). NF-{kappa}B and Oct-2 Synergize to Activate the Human 3' Igh hs4 Enhancer in B Cells. J. Immunol.
172: 1054-1064
[Abstract]
[Full Text]
-
Williams, D. C. Jr., Cai, M., Clore, G. M.
(2004). Molecular Basis for Synergistic Transcriptional Activation by Oct1 and Sox2 Revealed from the Solution Structure of the 42-kDa Oct1{middle dot}Sox2{middle dot}Hoxb1-DNA Ternary Transcription Factor Complex. J. Biol. Chem.
279: 1449-1457
[Abstract]
[Full Text]
-
Brunner, C., Laumen, H., Nielsen, P. J., Kraut, N., Wirth, T.
(2003). Expression of the Aldehyde Dehydrogenase 2-like Gene Is Controlled by BOB.1/OBF.1 in B Lymphocytes. J. Biol. Chem.
278: 45231-45239
[Abstract]
[Full Text]
-
Jankovic, M., Nussenzweig, M. C.
(2003). OcaB regulates transitional B cell selection. Int Immunol
15: 1099-1104
[Abstract]
[Full Text]
-
Akizawa, Y., Nishiyama, C., Hasegawa, M., Maeda, K., Nakahata, T., Okumura, K., Ra, C., Ogawa, H.
(2003). Regulation of human Fc{epsilon}RI {beta} chain gene expression by Oct-1. Int Immunol
15: 549-556
[Abstract]
[Full Text]
-
Samardzic, T., Marinkovic, D., Nielsen, P. J., Nitschke, L., Wirth, T.
(2002). BOB.1/OBF.1 Deficiency Affects Marginal-Zone B-Cell Compartment. Mol. Cell. Biol.
22: 8320-8331
[Abstract]
[Full Text]
-
Shore, P., Dietrich, W., Corcoran, L. M.
(2002). Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1. Nucleic Acids Res
30: 1767-1773
[Abstract]
[Full Text]
-
Niwa, H., Masui, S., Chambers, I., Smith, A. G., Miyazaki, J.-i.
(2002). Phenotypic Complementation Establishes Requirements for Specific POU Domain and Generic Transactivation Function of Oct-3/4 in Embryonic Stem Cells. Mol. Cell. Biol.
22: 1526-1536
[Abstract]
[Full Text]
-
Andersen, B., Rosenfeld, M. G.
(2001). POU Domain Factors in the Neuroendocrine System: Lessons from Developmental Biology Provide Insights into Human Disease. Endocr. Rev.
22: 2-35
[Abstract]
[Full Text]
-
Stein, H., Marafioti, T., Foss, H.-D., Laumen, H., Hummel, M., Anagnostopoulos, I., Wirth, T., Demel, G., Falini, B.
(2001). Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood
97: 496-501
[Abstract]
[Full Text]
-
Fernández, L. A., Winkler, M., Grosschedl, R.
(2001). Matrix Attachment Region-Dependent Function of the Immunoglobulin {micro} Enhancer Involves Histone Acetylation at a Distance without Changes in Enhancer Occupancy. Mol. Cell. Biol.
21: 196-208
[Abstract]
[Full Text]
-
Röckelein, I., Röhrig, S., Donhauser, R., Eimer, S., Baumeister, R.
(2000). Identification of Amino Acid Residues in the Caenorhabditis elegans POU Protein UNC-86 That Mediate UNC-86-MEC-3-DNA Ternary Complex Formation. Mol. Cell. Biol.
20: 4806-4813
[Abstract]
[Full Text]
-
Ishii, Y., Hansen, A. J., Mackenzie, P. I.
(2000). Octamer Transcription Factor-1 Enhances Hepatic Nuclear Factor-1alpha -Mediated Activation of the Human UDP Glucuronosyltransferase 2B7 Promoter. Mol. Pharmacol.
57: 940-947
[Abstract]
[Full Text]
-
Schubart, D. B., Rolink, A., Schubart, K., Matthias, P.
(2000). Cutting Edge: Lack of Peripheral B Cells and Severe Agammaglobulinemia in Mice Simultaneously Lacking Bruton's Tyrosine Kinase and the B Cell-Specific Transcriptional Coactivator OBF-1. J. Immunol.
164: 18-22
[Abstract]
[Full Text]
-
Chasman, D., Cepek, K., Sharp, P. A., Pabo, C. O.
(1999). Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface. Genes Dev.
13: 2650-2657
[Abstract]
[Full Text]
-
Krapp, A., Strubin, M.
(1999). B-Cell Coactivator OBF-1 Exhibits Unusual Transcriptional Properties and Functions in a DNA-Bound Oct-1-Dependent Fashion. Mol. Cell. Biol.
19: 4247-4254
[Abstract]
[Full Text]
-
LUO, Y., ROEDER, R.G.
(1999). B-cell-specific Coactivator OCA-B: Biochemical Aspects, Role in B-Cell Development and Beyond. Cold Spring Harb Symp Quant Biol
64: 119-132
[Abstract]
-
Kakizawa, T., Miyamoto, T., Ichikawa, K., Takeda, T., Suzuki, S., Mori, J.-i., Kumagai, M., Yamashita, K., Hashizume, K.
(2001). Silencing Mediator for Retinoid and Thyroid Hormone Receptors Interacts with Octamer Transcription Factor-1 and Acts as a Transcriptional Repressor. J. Biol. Chem.
276: 9720-9725
[Abstract]
[Full Text]